CRM: Anthropic Just Tanked Its Own Partner 6%

This is a sector-wide derating, not a Salesforce-specific problem. The difference is that Salesforce has $14.4 billion in free cash flow and a $50 billion buyback authorization to exploit the dislocation.

Salesforce reported Q4 FY2026 revenue of $11.20 billion, up 12% year-over-year and accelerating from Q3's $10.26 billion. Full-year revenue hit $41.5 billion with net income of $7.46 billion. The operating margin expanded to 21.9% in Q4, and gross margin held at 77.6% — the kind of profitability profile that makes this a capital return machine.

The cash flow story is even better. Operating cash flow came in at $15.0 billion for the full year, converting to $14.4 billion in free cash flow. Income quality — operating cash flow divided by net income — sits at 2.81x. That ratio means Salesforce generates nearly three dollars of cash for every dollar of reported earnings. This is not financial engineering. This is a subscription business with massive deferred revenue collecting cash before recognizing it.

Quarterly EPS progression tells the same story: $1.59, $1.96, $2.18, and $2.07 across FY2026. The Q4 dip from Q3 reflects seasonality and investment timing, not deterioration. Full-year EPS of $7.81 on a $184 stock gives you a 23.6x trailing multiple. Analyst estimates project quarterly EPS ramping to $4.03-$4.65 by FY2029, which would put the forward PE somewhere around 10-11x on current prices. The market is pricing this like a company in decline while the numbers show a company accelerating.

R&D spending hit $1.62 billion in Q4, or 14.5% of revenue. Salesforce is not cutting investment to juice margins — it is spending aggressively on Agentforce and Data Cloud while still expanding profitability. Stock-based compensation at 9.7% of revenue is elevated but declining as a percentage, and the buyback program more than offsets dilution.

The bear thesis requires you to believe that AI will destroy enterprise CRM while ignoring that Salesforce is the enterprise AI leader in its category. Agentforce reached $800 million in annual recurring revenue growing 169% year-over-year. The company has closed 29,000 Agentforce deals. Combined with Data 360, the AI-adjacent business runs at $1.4 billion ARR growing 114%.

The platform has processed 19 trillion AI tokens and 2.4 billion cumulative agentic work units. These are not pilot numbers. These are production-scale deployment metrics from a platform embedded across Salesforce's customer base. Agentforce is now included in SMB Suites at no extra charge — a land-and-expand strategy that seeds AI capabilities across the install base and creates upsell opportunities for premium tiers.

The market's position is internally contradictory. If AI agents are the future of enterprise productivity — which is the stated reason for selling SaaS stocks — then Salesforce is building exactly the right product. Agentforce is not a defensive response to AI disruption. It launched before the current panic. It is growing faster than any Salesforce product line in history. The $800 million ARR number would make it a standalone unicorn if it were a separate company, and it is only 18 months old.

Management's capital allocation tells you what insiders think about the stock price. Salesforce authorized a $50 billion share buyback program — equivalent to 27% of the current $172.6 billion market cap. In FY2026 alone, the company spent $12.6 billion on repurchases and $1.59 billion on dividends, returning $14.2 billion to shareholders against $14.4 billion in free cash flow. That is a 98.6% shareholder return ratio.

To fund the accelerated buyback, Salesforce increased net debt by $5.4 billion. The balance sheet can handle it: debt-to-equity sits at 0.29x and net debt-to-EBITDA at 2.6x. Cash per share is $10.23. This is not a company leveraging itself into distress — it is a company with $15 billion in annual operating cash flow using cheap debt to buy back stock it considers undervalued.

The math on buybacks at current prices is compelling. At $184 per share with 937 million shares outstanding, the remaining buyback authorization could retire roughly 20% of outstanding shares at today's price. Every dollar spent on buybacks at this valuation is more accretive than it was six months ago when the stock was above $250. Management is not being subtle about this — the $25 billion debt-funded buyback component is an aggressive signal that they view the selloff as a gift. Free cash flow yield stands at 2.7% based on reported FCF per share of $5.69, but that understates the real return because the buyback is shrinking the share count simultaneously.

At $184.17, CRM trades at 23.6x trailing earnings on $7.81 EPS and roughly 15x forward estimates. The EV/EBITDA of 55.6x looks elevated until you realize that is distorted by the heavy buyback-related debt load on a company whose EBITDA is growing double digits. Price-to-book is 3.36x. ROE is modest at 3.3%, depressed by Salesforce's massive goodwill from historical acquisitions — the economic return on invested capital is substantially higher.

The 52-week range tells the story: high of $296.05, low of $174.57. The stock is $9.60 above its 52-week low and $111.88 below its high. The 50-day moving average is $206.06 and the 200-day is $240.95 — CRM is trading well below both, indicating extreme negative sentiment.

Compare this to what you are buying: a company growing revenue 10-12%, generating $14.4 billion in free cash flow, with the leading enterprise AI product in its category, aggressive buybacks, and a fortress balance sheet. The SaaS derating has compressed CRM's multiple from north of 35x to under 24x trailing in six months. If you believe enterprise software still has customers in three years — and every Fortune 500 company's IT budget confirms it does — this is a valuation that prices in significant permanent impairment that is not occurring.

Analyst estimates for FY2029 project quarterly revenue ramping from $13.4 billion to $15.0 billion, implying annual revenue approaching $57 billion. At 15x forward earnings on an EPS trajectory toward $16-18 annually, CRM would be a $240-$270 stock. That is 30-47% upside from here, plus the buyback is reducing your share count while you wait.

The legitimate risks deserve acknowledgment. SaaS valuations can stay compressed longer than anyone expects if the AI disruption narrative persists. Salesforce's heavy reliance on seat-based pricing faces structural pressure if AI agents reduce headcount at customer organizations — fewer sales reps means fewer Salesforce licenses. The $5.4 billion in new debt is manageable today but reduces flexibility if a recession hits.

Agentforce's 169% growth rate will inevitably decelerate. The question is whether usage-based AI revenue can offset any pressure on traditional seat-based revenue. At $800 million ARR, Agentforce is still less than 2% of total revenue — meaningful but not yet transformative. The company needs Agentforce to reach $5-10 billion ARR before it materially changes the growth trajectory.

Stock-based compensation at 9.7% of revenue remains a headwind. While buybacks offset dilution, SBC is a real economic cost that flatters operating margins. And Salesforce's acquisition history — Slack, Tableau, MuleSoft — has created a goodwill-heavy balance sheet where the ROE math looks worse than the underlying economics.

The next earnings report on May 27, 2026 will be critical. If Agentforce ARR accelerates past $1 billion and the company guides for continued revenue acceleration, the narrative shifts. If growth disappoints, the selloff deepens. The stock is approaching its 52-week low of $174.57 with limited technical support below that level.